Proof of principle for epitope-focused vaccine design
Open accessThe DOI matches its Crossref record; 37 of the 38 references it cites were found in a registry or an index.
Abstract
Vaccines prevent infectious disease largely by inducing protective neutralizing antibodies against vulnerable epitopes. Several major pathogens have resisted traditional vaccine development, although vulnerable epitopes targeted by neutralizing antibodies have been identified for several such cases. Hence, new vaccine design methods to induce epitope-specific neutralizing antibodies are needed. Here we show, with a neutralization epitope from respiratory syncytial virus, that computational protein design can generate small, thermally and conformationally stable protein scaffolds that accurately mimic the viral epitope structure and induce potent neutralizing antibodies. These scaffolds represent promising leads for the research and development of a human respiratory syncytial virus vaccine needed to protect infants, young children and the elderly. More generally, the results provide proof of principle for epitope-focused and scaffold-based vaccine design, and encourage the evaluation and further development of these strategies for a variety of other vaccine targets, including antigenically highly variable pathogens such as human immunodeficiency virus and influenza.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures














Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Previous methods can scaffold functional sites made up of one or two contiguous chain segments (6–10), but with the exception of helical bundles (8) these do not extend readily to more complex sites composed of three or more chain segments, and the generated backbones are not guaranteed to be designable (encodable by some amino acid sequence).”
From Scaffolding protein functional sites using deep learning (2022) · cites this paper as [7]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Previous methods can scaffold functional sites made up of one or two contiguous chain segments (6–10), but with the exception of helical bundles (8) these do not extend readily to more complex sites composed of three or more chain segments, and the generated backbones are not guaranteed to be designable (encodable by some amino acid sequence).”
From Scaffolding protein functional sites using deep learning (2022) · cites this paper as [7]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Previous methods can scaffold functional sites made up of one or two contiguous chain segments (6–10), but with the exception of helical bundles (8) these do not extend readily to more complex sites composed of three or more chain segments, and the generated backbones are not guaranteed to be designable (encodable by some amino acid sequence).”
From Scaffolding protein functional sites using deep learning (2022) · cites this paper as [7]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
NMRPipe: A multidimensional spectral processing system based on UNIX pipes
Delaglio, F., Grzesiek, S., Vuister, G., Zhu, G., Pfeifer, J., & Bax, A. (1995) · Journal of Biomolecular NMR · doi:10.1007/bf00197809 · Cited by 15,965
Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., Abraham, J., Adair, T., Aggarwal, R., Ahn, S. Y., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61728-0 · Cited by 14,070
The global distribution and burden of dengue
Bhatt, S., Gething, P. W., Brady, O. J., Messina, J. P., Farlow, A. W., Moyes, C. L., Drake, J. M., Brownstein, J. S., Hoen, A. G., Sankoh, O., et al. (2013) · Nature · doi:10.1038/nature12060 · Cited by 10,037
Murray, C. J. L., Vos, T., Lozano, R., Naghavi, M., Flaxman, A. D., Michaud, C., Ezzati, M., Shibuya, K., Salomon, J. A., Abdalla, S., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61689-4 · Cited by 8,888
NMR View: A computer program for the visualization and analysis of NMR data
Johnson, B. A., & Blevins, R. A. (1994) · Journal of Biomolecular NMR · doi:10.1007/bf00404272 · Cited by 3,090
Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
Rerks-Ngarm, S., Pitisuttithum, P., Nitayaphan, S., Kaewkungwal, J., Chiu, J., Paris, R., Premsri, N., Namwat, C., de Souza, M., Adams, E., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0908492 · Cited by 3,034
Leaver-Fay (2011) · doi:10.1016/b978-0-12-381270-4.00019-6 · Cited by 1,904
Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis
Osterholm, M. T., Kelley, N. S., Sommer, A., & Belongia, E. A. (2012) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70295-x · Cited by 1,789
Protein Structure Prediction Using Rosetta
Rohl, C. A., Strauss, C. E. M., Misura, K. M. S., & Baker, D. (2004) · Methods in Enzymology · doi:10.1016/s0076-6879(04)83004-0 · Cited by 1,725
Self-citationDesign of a Novel Globular Protein Fold with Atomic-Level Accuracy
Kuhlman, B., Dantas, G., Ireton, G. C., Varani, G., Stoddard, B. L., & Baker, D. (2003) · Science · doi:10.1126/science.1089427 · Cited by 1,670
Self-citation
Research works printed but not linked: 1
- Plotkin SA Orenstein WA Offit PA Vaccines 6 Elsevier 2012
Cited by
Items 401–500 of 554
Paquet, E., Soleymani, F., St-Pierre-Lemieux, G., Viktor, H. L., & Michalowski, W. (2023) · Artificial Intelligence Chemistry · doi:10.1016/j.aichem.2023.100030 · Cited by 6
Yi, G., Tu, X., Bharaj, P., Guo, H., Zhang, J., Shankar, P., & Manjunath, N. (2015) · Molecular Therapy · doi:10.1038/mt.2015.107 · Cited by 6
Exploring Human Antimicrobial Antibody Responses on a Single B Cell Level
Hofmann, D., & Lai, J. R. (2017) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00544-16 · Cited by 6
Homology Modeling of Antibody Variable Regions: Methods and Applications
Bansia, H., & Ramakumar, S. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-2974-1_16 · Cited by 5
Designer Proteins to Trigger Cell Death
Fairbrother, W. J., & Ashkenazi, A. (2014) · Cell · doi:10.1016/j.cell.2014.06.010 · Cited by 5
A Shot in the Arm for HIV Prevention? Recent Successes and Critical Thresholds
Hope, T. J., & Marrazzo, J. M. (2015) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2015.0310 · Cited by 6
“Utilizing highly specialized antigens, designed to present specific epitopes to the immune system, it was possible to stimulate highly potent antibodies to RSV and influenza.(19,20) This success supports the potential development of unique HIV antigens that stimulate more potent and protective immune responses.”
BackgroundShao, S., Zhang, X., Hou, J. W., Yang, S., Han, Z. B., Wu, H. L., Tang, F., Li, X. Y., Lei, Z. H., Zhao, Z. X., et al. (2024) · npj Vaccines · doi:10.1038/s41541-024-00855-7 · Cited by 5
“However, the constructed chimeric VLP failed to induce neutralizing response in mice 23 .”
Analysis of Human RSV Immunity at the Molecular Level: Learning from the Past and Present
Vaughan, K. C., Ponomarenko, J. V., Peters, B., & Sette, A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0127108 · Cited by 5
Wilson, C. B. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00064 · Cited by 4
“Elucidation of the structure of the RSV F protein in complex with these and other neutralizing monoclonal antibodies has led to the structure based-design of recombinant F protein vaccines stabilized or scaffolded in a pre-fusion confirmation, which induce protective antibodies in nonhuman primates (19, 20).”
BackgroundMelero, J. A. (2016) · Expert Review of Vaccines · doi:10.1080/14760584.2016.1175941 · Cited by 6
Broadly Neutralizing Antibodies
Morris, L., & Moody, T. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-802302-0.00012-1 · Cited by 8
MaSIF - Deciphering interaction fingerprints from protein molecular surfaces
Gaínza, P., Sverrisson, F., Monti, F., Rodolà, E., Bronstein, M. M., & Correia, B. E. (2019) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.2625419 · Cited by 6
Self-citationAntibodies: Computer-Aided Prediction of Structure and Design of Function
Sevy, A. M., & Meiler, J. (2015) · ASM Press eBooks · doi:10.1128/9781555817411.ch10 · Cited by 4
An Epitope‐Specific Respiratory Syncytial Virus Vaccine Based on an Antibody Scaffold
Luo, X., Liu, T., Wang, Y., Jia, H., Zhang, Y., Caballero, D., Du, J., Wang, R. E., Wang, D., Schultz, P. G., et al. (2015) · Angewandte Chemie · doi:10.1002/ange.201507928 · Cited by 4
Biotechnological and Biomedical Applications of Protein Engineering Methods
Poluri, K. M., & Gulati, K. (2016) · SpringerBriefs in applied sciences and technology · doi:10.1007/978-981-10-2732-1_5 · Cited by 4
Computational design of proteins with novel structure and functions
Yang, W., & Lai, L. (2016) · Chinese Physics B · doi:10.1088/1674-1056/25/1/018702 · Cited by 5
Barber, N. M., Lau, C. K., Turner, L., Watson, G., Thrane, S., Lusingu, J., Lavstsen, T., & Higgins, M. K. (2021) · mSphere · doi:10.1128/msphere.01081-20 · Cited by 4
“We therefore grafted the helix-kinked-helix motif onto this scaffold and used a Rosetta-based strategy (25, 30) to redesign the resultant molecule to obtain the appropriate fold (Fig.”
MethodVaccine against COVID-19 or against SARS-CoV-2 infection?
Rieske, P. (2020) · Alergologia Polska - Polish Journal of Allergology · doi:10.5114/pja.2020.97913 · Cited by 5
A bottom-up approach for the de novo design of functional proteinsPreprint
Yang, C., Sesterhenn, F., Bonet, J., van Aalen, E. A., Scheller, L., Abriata, L. A., Cramer, J., Wen, X., Rosset, S., Georgeon, S., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.03.11.988071 · Cited by 4
“The design of novel functional proteins is a fundamental test to our understanding of protein structure and function, and has enormous potential in multiple arenas in basic biology and biotechnology (7-15, 17).”
BackgroundSelf-citationCryo-EM led analysis of open and closed conformations of Chagas vaccine candidate TcPOP
Batra, S., Olmo, F., Ragan, T. J., Kaplan, M., Calvaresi, V., Frank, A. M., Lancey, C., Assadipapari, M., Ying, C., Struwe, W. B., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-62068-3 · Cited by 2
“Suchdataare invaluable to initiate structure-based immunogen design strategies that focustheimmuneresponsetowardskey conserved epitopes 31 and to identify regions within the target protein suitable for drug design.”
Chen, L., Yan, P., Duan, L., Ming, G., Wang, X., Zhang, J., Chen, Z., Gou, Q., Yuan, Y., Jing, H., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1697829 · Cited by 3
“Current vaccine development strategies show that whole-antigen vaccines exhibit inferior ef fi cacy compared with those of epitope-speci fi c formulations (25) as protective immunity can be effectively elicited even by limited immunodominant epitopes (26).”
Dickey, T. H., McAleese, H., Salinas, N. D., Lambert, L., & Tolia, N. H. (2024) · Protein Science · doi:10.1002/pro.5095 · Cited by 3
Zhang, J., Yang, Y., Wang, B., Qiu, W., Zhang, H., Qiu, Y., Yuan, J., Dong, R., & Zha, Y. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1427677 · Cited by 4
Sahni, R., Kumar, N., & Raghava, G. P. S. (2025) · Protein Science · doi:10.1002/pro.70212 · Cited by 4
“Identifying these antibody-binding regions is crucial for advancing immunological research and enabling the development of vaccines, therapeutics, and diagnostic tools (Correia et al. 2014; Csepregi et al. 2020; Norman et al. 2020).”
Combining System Design and Path Planning
Denarie, L., Molloy, K., Vaisset, M., Siméon, T., & Cortés, J. (2020) · Springer proceedings in advanced robotics · doi:10.1007/978-3-030-43089-4_8 · Cited by 3
Epitope prediction and selection of linkers and adjuvant
Arya, H. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821471-8.00008-8 · Cited by 3
De novo design of stable proteins that efficaciously inhibit oncogenic G proteins
Cummins, M. C., Tripathy, A., Sondek, J., & Kuhlman, B. A. (2023) · Protein Science · doi:10.1002/pro.4713 · Cited by 3
Controllable Protein Design by Prefix-Tuning Protein Language Models
Luo, J., Li, J., Liu, X., Zhang, Y., Chen, Q., & Chen, J. (2026) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5c03186 · Cited by 9
Biophysical fitness landscape design traps viral evolution
Mohanty, V., & Shakhnovich, E. I. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2611571123 · Cited by 5
“Current pandemic preparedness strategies involving vaccination are often shortsighted, focused on targeting today’s most prevalent antigens 26–28 but can fail to account for tomorrow’s inevitable escape mutations 29 .”
Design of immunogens to present a tumor-specific cryptic epitope
Xu, H., Palpant, T., Wang, Q., & Shaw, D. E. (2025) · Scientific Reports · doi:10.1038/s41598-025-94295-5 · Cited by 4
“…to the immunogen composition 35–37 and immunization protocols 38,39 could enhance immunogenicity and focus the antibody response against the epitope, 11 potentially leading to immunogens that can overcome the obstacles outlined above and robustly elicit mAb806-like, cancer-selective antibodies.”
Recombinant Technologies to Improve Ruminant Production Systems: The Past, Present and Future
Pech-Cervantes, A. A., Irfan, M., Estrada-Reyes, Z. M., & Ogunade, I. M. (2020) · Processes · doi:10.3390/pr8121633 · Cited by 3
Barrett, J., Leysen, S., Galmiche, C., Al‐Mossawi, H., Bowness, P., Edwards, T. E., & Lawson, A. D. G. (2024) · Bioengineered · doi:10.1080/21655979.2023.2299522 · Cited by 2
“Mindful of the approach of Correia and colleagues [15], chimeric constructs were designed and wild type GPR65 extracellular loops were successfully displayed on the alpha-helix of soluble ApoE3, when substituted at the specific joining site between the loop and alpha-helix.”
BackgroundMethodMultimodal diffusion for joint design of protein sequence and structure
Zhu, S., Gulati, S., Liu, Y., Kotnis, S., Sun, Q. H., & Shen, Y. (2025) · Protein Science · doi:10.1002/pro.70340 · Cited by 5
Li, X., Ye, H., Ge, X., Zhou, L., Guo, X., Han, J., Zhang, Y., & Yang, H. (2026) · Veterinary Research · doi:10.1186/s13567-025-01690-x · Cited by 2
“For vaccine development, epitope-based vaccines offer advantages over full-length protein vaccines, including reduced risk of antibody-dependent enhancement and focused induction of neutralizing responses [46, 47].”
De novo protein design: a transformative frontier in clinical protein applications
Gao, J., Zheng, Z., Yu, X., Luo, Y., Yu, Y., & Zhang, C. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-07784-0 · Cited by 4
“In contrast, de novo designed scaffolds can maintain the structural integrity of discontinuous epitopes [44] and allow coordinated presentation of multiple epitopes [114, 115], thereby enhancing vaccine stability and immunogenicity.”
Song, S., Ge, H., Yuan, D., Gu, X., Lu, W., Ding, C., Qin, Y., Gao, S., Lin, X., Cheng, H., et al. (2026) · npj Vaccines · doi:10.1038/s41541-026-01412-0 · Cited by 3
Charron, C. A., Kaldis, A., Shamriz, S., Diarra, M. S., Garnham, C. P., & Menassa, R. (2026) · FEBS Journal · doi:10.1111/febs.70561 · Cited by 3
Dueker, K., Capozzola, T., Feng, Z., Lin, R. N., Hurtado, J., Bangaru, S., Yuan, M., Beutler, N., Garcia, E., He, W.-T., et al. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117439 · Cited by 3
Guliás, P., Sueiro, R. A., Lamas, J., & Leiro, J. M. (2026) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2026.111561 · Cited by 2
Hassan, W. S., Brock, C., & Esteve‐Gasent, M. D. (2022) · Al-mağallaẗ al-ʻirāqiyyaẗ li-l-ʻulūm al-bayṭariyyaẗ/Iraqi journal of veterinary sciences · doi:10.33899/ijvs.2022.135519.2487 · Cited by 3
Drug Design Methods to Regulate Protein–Protein Interactions
Poluri, K. M., Gulati, K., Tripathi, D. K., & Nagar, N. (2023) · Springer eBooks · doi:10.1007/978-981-99-2423-3_6 · Cited by 4
Soltan, M. A., Abdulsahib, W. K., Eid, R. A., Alshaya, D. S., Sideeg, A. M., Osman, R., Alarabi, T. G. M., Mohamed, G., Al‐Salmi, F. A., Fayad, E., et al. (2024) · Journal of Computational Biophysics and Chemistry · doi:10.1142/s2737416524500376 · Cited by 2
PB-GPT: An innovative GPT-based model for protein backbone generation
Min, X., Liao, Y., Chen, X., Yang, Q., Ying, J., Zou, J., Yang, C., Zhang, J., Ge, S., & Xia, N. (2024) · Structure · doi:10.1016/j.str.2024.07.016 · Cited by 2
Ling, X., Cai, C., Kong, D., Wei, Z., Wu, J., Wang, L., & Deng, Z. (2025) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5c00378 · Cited by 3
Lansoprazole induces collagenous colitis in the colon of Mongolian gerbils.
Mizushima, T., Mizoshita, T., Sasaki, M., Tanida, S., Tsukamoto, H., Shimura, T., Kanematsu, T., Kataoka, H., Kamiya, T., Tsukamoto, T., et al. (2011) · PubMed · Cited by 2
Ni, H., Zhuang, Y., Chen, Z., & Ji, W. (2017) · Molecular Simulation · doi:10.1080/08927022.2017.1383989 · Cited by 2
Studies on computational grafting of malarial epitopes in serum albumin
Mishra, S., & Manish, M. (2018) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2018.09.018 · Cited by 2
Humoral immunity in tuberculosis
Jacobs, A., & Wilkinson, R. J. (2015) · European Journal of Immunology · doi:10.1002/eji.201570034 · Cited by 2
Cardozo, T. J., Shmelkov, S. V., Carr, K. D., Rotrosen, J., Mateu‐Gelabert, P., & Friedman, S. R. (2015) · Springer eBooks · doi:10.1007/978-3-319-23150-1_6 · Cited by 4
Functional reconstitution of the MERS CoV receptor binding motif
Uppalapati, L., Roitburd‐Berman, A., Weiss-Ottolenghi, Y., Graham, B. S., Dimitrov, D. S., Ying, T., Failayev, H., Tsfadia, Y., & Gershoni, J. M. (2022) · Molecular Immunology · doi:10.1016/j.molimm.2022.03.006 · Cited by 2
Self-citationEarly Recognition of Emerging Flu Strain ClustersPreprint
Li, A., Phillips, J. C., & Deem, M. W. (2015) · arXiv (Cornell University) · doi:10.48550/arxiv.1512.08442 · Cited by 2
“to developing an effective flu vaccine. Traditional measurements of viral antigenicity or phylogenetic theories, or their combination, omit highly informative structural data used to define epitopes [22, 23, 24], and have had only limited success (R 2 ~ 0.5). Dimensional reduction in three- year time-frame sliding seq…”
BackgroundInfluentialSmall Functional Peptides and Their Application in Superfunctionalizing Proteins
Billerbeck, S. (2018) · Wiley eBooks · doi:10.1002/9783527688104.ch11 · Cited by 2
Bekkering, E. T., Yoo, R., Hailemariam, S., Heide, F., Ivanochko, D., Jackman, M. J., Proellochs, N. I., Stoter, R., van Gemert, G.-J., Maeda, A., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.02.14.638310 · Cited by 2
Rijal, P., Wei, L., Paesen, G. C., Stuart, D. I., Howarth, M. R., Huang, K.-Y. A., Bowden, T. A., & Townsend, A. (2025) · eLife · doi:10.7554/elife.105317 · Cited by 2
“…on interactions between monomers encoded in the remainder of the NA sequence (the ‘scaffold’), and (3) the structure of the loops will be maintained when grafted from one scaffold to another, at least within an NA subtype ( Musunuri et al., 2024 ; Correia et al., 2014 ; Schoeder et al., 2021 ).”
Hauser, B. M., Sangesland, M., Lam, E. C., Denis, K. S., Sheehan, M. L., Vu, M. L., Cheng, A. H., Sordilla, S., Thornlow, D. N., Almawi, A. W., et al. (2024) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.3c00483 · Cited by 1
Zheng, Z., Zhang, B., Zhong, B., Yu, J., Liu, K., Li, Z., Zhu, J., Wei, T., & Chen, H.-F. (2026) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1014290 · Cited by 1
Liu, B., Bai, M., Zheng, F., Yan, M., Huang, E., Wen, J., Li, Y., & Wang, J. (2025) · Vaccines · doi:10.3390/vaccines13030239 · Cited by 4
Self-citationGürcan, F. (2025) · PeerJ Computer Science · doi:10.7717/peerj-cs.2970 · Cited by 2
“As such, the accurate identi fi cation of epitopes directly impacts vaccine ef fi cacy ( Correia et al., 2014 ; Palma, 2023 ).”
Identification of linear B-cell epitopes on the gE envelope protein of varicella-zoster virus
Niu, Y., Zhou, J., Liu, Y., Wang, H., Liu, H., Chen, Y., Zhu, X., Liang, C., & Wang, A. (2025) · Microbiology Spectrum · doi:10.1128/spectrum.00723-25 · Cited by 1
“The epitope-focused vaccines have become a hot spot and trend in vaccine development due to their strong pertinency and slight side effects (24).”
Blanco, E., Torres, E., de León, P., Forner, M., Bustos, M. J., Hammer, S. E., Sobrino, F., Andreu, D., & Defaus, S. (2025) · npj Vaccines · doi:10.1038/s41541-025-01274-y · Cited by 2
“In such peptide-based formulations, selected antigenic motifs canbepurposefullyintegratedintohigher-orderassemblieselicitingbothB-andT-cellimmuneresponses 18,19 , conferring protection, adaptability, and multivalency 20,21 .”
Iborra-Pernichi, M., de León, P., Torres, E., Defaus, S., Blanco, E., Andreu, D., Martínez, N., & Sobrino, F. (2026) · Scientific Reports · doi:10.1038/s41598-026-42982-2 · Cited by 1
Shafaati, M., Jamnani, F. N., & Ghorbani, M. (2026) · Immunologic Research · doi:10.1007/s12026-026-09763-5 · Cited by 3
Rational design of an optimized ferritin nanoparticle vaccine targeting both SARS-CoV-2 and MERS-CoV
Liu, Y., Rao, H., Wang, N., Liu, X., Chen, T., Zhang, B., Lai, J., Shan, J., Xiao, S., Peng, H., et al. (2026) · Journal of Nanobiotechnology · doi:10.1186/s12951-026-04738-y · Cited by 2
“The induction of effective nAbs against viruses relies on the proper presentation of neutralizing epitopes on vaccines [51].”
Self-citationIdentification and characterization of antibodies elicited by human cystatin C fragment
Behrendt, I., Prądzińska, M., Spodzieja, M., Czaplewska, P., Kołodziejczyk, A. S., Szymańska, A., Kasprzykowski, F., Lundström, S. L., Zubarev, R. A., & Rodziewicz‐Motowidło, S. (2017) · Journal of Molecular Recognition · doi:10.1002/jmr.2689 · Cited by 1
“Today, the efforts are directed to design an epitope‐focused specific vaccine antigen, which is a promising approach to the treatment of many infectious diseases, eg, influenza or respiratory syncytial virus.(36) In this work, we tested the ability of the hCC fragment 60‐70 (VNYFLDVELGR) to trigger an immunological re…”
BackgroundShafaati, M., Jajan, L. H.-G., Ebadi, M., Zarghami, V., & Ghorbani, M. (2024) · World s Poultry Science Journal · doi:10.1080/00439339.2024.2308227 · Cited by 1
“They give more surface plasmon resonance and circular dichroism information on potential vaccine candidate antigens than methods like two-dimensional gel electrophoresis, mass spectrometry, and DNA microarrays (Correia et al .”
BackgroundMethodInfluentialThe construction of a peptide vaccine with multifunctional DNA tetrahedron exoskeleton
Liang, J., Qin, X., Xu, S., Zhang, M., Yao, L., Liu, Z., Zhang, G., Tian, T., & Lin, Y. (2024) · Chemical Engineering Journal · doi:10.1016/j.cej.2024.157911 · Cited by 2
Rijal, P., Wei, L., Paesen, G. C., Stuart, D. I., Howarth, M. R., Huang, K.-Y. A., Bowden, T. A., & Townsend, A. (2025) · eLife · doi:10.7554/elife.105317.3 · Cited by 2
Kramer, V. G., & Byrareddy, S. N. (2014) · Expert Review of Vaccines · doi:10.1586/14760584.2014.928597 · Cited by 1
“A novel respiratory syncytial virus vaccine candidate was generated using computational protein design to improve scaffold proteins [24].”
MethodPrediction (early recognition) of emerging flu strain clusters
Li, X., & Phillips, J. C. (2017) · Physica A Statistical Mechanics and its Applications · doi:10.1016/j.physa.2017.02.073 · Cited by 2
The path toward an HIV-1 vaccine
Garcés, F. (2017) · Porto Biomedical Journal · doi:10.1016/j.pbj.2017.06.002 · Cited by 1
Conserved Structural Anatomy Between Divergent Viral Capsid Nanoparticles for Vaccine Design
McCraw, D. M., Gulati, N. M., Myers, M. L., & Harris, A. K. (2018) · Microscopy and Microanalysis · doi:10.1017/s1431927618007092 · Cited by 1
Entwicklungsansätze für Impfstoffe gegen Hepatitis-C-Virus-Infektionen
Bankwitz, D., Krey, T., & Pietschmann, T. (2022) · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · doi:10.1007/s00103-021-03477-9 · Cited by 1
Human Immunodeficiency Virus Vaccines
Girard, M. P., & Koff, W. C. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35761-6.00029-8 · Cited by 4
Havenar‐Daughton, C., Carnathan, D. G., Boopathy, A. V., Upadhyay, A. A., Murrell, B., Reiss, S. M., Enemuo, C. A., Gebru, E. H., Chloe, Y., Dhadvai, P., et al. (2019) · SSRN Electronic Journal · doi:10.2139/ssrn.3387660 · Cited by 2
Self-citationDingens, A. S., Pratap, P. P., Malone, K. D., Hilton, S. K., Ketas, T. J., Cottrell, C. A., Overbaugh, J. M., Moore, J. P., Klasse, P. J., Ward, A. B., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.10.21.348623 · Cited by 1
“While both rational, structure-based vaccine design (Alam et al., 2017; Correia et al., 2014; Dubrovskaya et al., 2019; Haynes et al., 2012; Kong et al., 2019; Kwong and Mascola, 2018; Saunders et al., 2017; Xu et al., 2018) and broadly neutralizing antibody germline-targeting (Briney et al., 2016;…”
Novel neutralization mechanism of a human antibody with pan-coronavirus reactivityPreprint
Sun, X., Yi, C., Zhu, Y., Ding, L., Xia, S., Gu, C., Lu, X., Chen, S., Yang, Z., Zhang, Y., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-952553/v1 · Cited by 1
A Generative Model for Creating Path Delineated Helical ProteinsPreprint
Kibler, R. D., Wicky, B. I. M., Coventry, B., & Woodall, N. B. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.05.24.542095 · Cited by 1
Marco, R. H. (2014) · Anales (Reial Acadèmia de Medicina de la Comunitat Valenciana)
López-Yglesias, A. H. (2014) · ResearchWorks at the University of Washington (University of Washington)
Greenberg, H. B., & Dormitzer, P. R. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-374279-7.14016-0
The Aging Immune System, Vaccine Efficacy, and the Lung
Bartley, J. M., & Haynes, L. (2015) · WORLD SCIENTIFIC eBooks · doi:10.1142/9789814635011_0009
Characterization of physicochemical environments of proteins
Tan, K. P. (2017) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/69607
Computational design of interleukin-2 mimetics
Yu, S. S. (2015) · ResearchWorks at the University of Washington (University of Washington)
Structure-guided design of a synthetic mimic of an EPCR-binding PfEMP1 proteinPreprint
Barber, N. M., Lau, C. K., Turner, L., Watson, G., Thrane, S., Lusingu, J., Lavstsen, T., & Higgins, M. K. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/749432
“Epitope grafting used the Rosetta package (31), and was based on the fold-fromloops protocol (25).”
BackgroundMethodGilliam, B. L., Redfield, R., & Peters, B. S. (2016) · Elsevier eBooks · doi:10.1016/b978-0-7020-6285-8.00091-5
Climate Change Adaptation Strategies for In-field Conservation Practices by Irrigated Farm
Wibowo, R. P. (2019) · IOP Conference Series Earth and Environmental Science · doi:10.1088/1755-1315/260/1/012020
“Conservation practices have two primary benefits such as conservation of water, soil and soil organic matter and also a reduction of costly input [2].”
BackgroundAnimal Shelter, Vaccination and Welfare
Pant, N., Deol, H., Chauhan, A., Mehra, A., Singh, A. K., & Kaur, B. (2021) · International Journal of Scientific Research in Computer Science Engineering and Information Technology · doi:10.32628/cseit2172137
Antibodies Targeting the Envelope of HIV-1
Mayr, L. M., & Zolla‐Pazner, S. (2015) · ASM Press eBooks · doi:10.1128/9781555817411.ch11
Regenmortel, M. H. V. V. (2019) · Springer eBooks · doi:10.1007/978-3-030-32459-9_19
Samanta, I., & Bandyopadhyay, S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815770-1.00031-6
Ivanochko, D., Fabra-García, A., Teelen, K., van de Vegte‐Bolmer, M., van Gemert, G., Newton, J. C., Semesi, A., de Bruijni, M. H. C., Bolscher, J. M., Ramjith, J., et al. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4199639
Métodos de modelagem da estrutura tridimensional de proteínas: Um guia teórico e prático
Santana, K., & Nahum, C. (2022) · doi:10.22533/at.ed.825222810 · Cited by 1
A ESTRUTURA E O PROBLEMA DE DOBRAMENTO DE PROTEÍNAS
da Costa, K. S., Lima, A. H., & Lameira, J. (2022) · doi:10.22533/at.ed.8252228101
APLICAÇÕES DA MODELAGEM POR HOMOLOGIA, AB INITIO E THREADING
Lima, A. H., dos Santos, A. M., & da Costa, K. S. (2022) · doi:10.22533/at.ed.8252228108
MÉTODOS DE PREDIÇÃO THREADING E AB INITIO
Lima, A. H., da Costa, K. S., & dos Santos, A. M. (2022) · doi:10.22533/at.ed.8252228105
MODELAGEM DE PROTEÍNAS NO MODELLER
da Costa, K. S., & Galúcio, J. M. P. (2022) · doi:10.22533/at.ed.8252228103
ATUAIS LIMITAÇÕES E PERSPECTIVAS DOS MÉTODOS THREADING E AB INITIO
da Costa, K. S., Lima, A. H., & dos Santos, A. M. (2022) · doi:10.22533/at.ed.8252228109
ALGORÍTMOS DE MODELAGEM THREADING E AB INITIO
Lima, A. H., da Costa, K. S., & dos Santos, A. M. (2022) · doi:10.22533/at.ed.8252228106
MÉTODOS DE PREDIÇÃO POR HOMOLOGIA
da Costa, K. S., Galúcio, J. M. P., & Silva, J. R. A. (2022) · doi:10.22533/at.ed.8252228102
MODELAGEM DE PROTEÍNAS NO I-TASSER
da Costa, K. S., & Lima, A. H. (2022) · doi:10.22533/at.ed.8252228107
Metadata
- Authors
- Correia, B. E., Bates, J. T., Loomis, R. J., Baneyx, G., Carrico, C., Jardine, J. G., Rupert, P., Correnti, C., Kalyuzhniy, O., Vittal, V., Connell, M. J., Stevens, E., Schroeter, A., Chen, M., MacPherson, S., Serra, A. M., Adachi, Y., Holmes, M. A., Li, Y., Klevit, R. E., Graham, B. S., Wyatt, R. T., Baker, D., Strong, R. K., Crowe, J. E., Johnson, P. R., & Schief, W. R.
- Affiliations
- Scripps Research Institute (US)
- Vanderbilt University Medical Center (US)
- Children's Hospital of Philadelphia (US)
- University of Washington (US)
- Fred Hutch Cancer Center (US)
- National Institutes of Health (US)
- Corresponding author
- Schief, William R.
- ORCID
- Venue
- Nature
- Published
- 2014-02-05
- Volume
- 507
- Issue
- 7491
- Pages
- 201-206
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4260937
- OpenAlex
- W2040299410
- Cited by
- 555
- References
- 38
- Citations by year
- 2026: 39 · 2025: 40 · 2024: 37 · 2023: 32 · 2022: 55 · 2021: 44 · 2020: 43 · 2019: 45 · 2018: 40 · 2017: 47 · 2016: 50 · 2015: 52 · 2014: 30
- FWCI
- 24.45
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- cc-by-nc
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion, cc-by-nc)
- PubMed Central (acceptedVersion, cc-by-nc)
- Funders
- Bill and Melinda Gates Foundation
- International AIDS Vaccine Initiative
- March of Dimes Foundation
- Children's Hospital of Philadelphia
- University of Washington
- National Institutes of Health
- Center for AIDS Research, University of Washington
- University of California, San Diego
- National Cancer Institute (T32CA080416)
- National Institute of General Medical Sciences (T32GM007270)
- National Institute of Allergy and Infectious Diseases (P30AI 36214, U54AI057141, U54 AI 005714, R01AI102766, UM1AI100663, R21AI088554, P01AI094419, P30AI036214, P30AI045008)
- Center for AIDS Research, University of California, San Diego
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › vaccines and immunoinformatics approaches
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
- Keywords
- RSV vaccine, neutralizing antibodies, computational protein design, protein scaffolds, antigenic determinants, vaccine development
- MeSH terms
- Animals, Antibodies, Monoclonal, Antibodies, Viral, Epitopes, Antigens, Viral, Enzyme-Linked Immunosorbent Assay, Macaca mulatta, Male, Mice, Inbred BALB C, Models, Molecular, Neutralization Tests, Protein Conformation, Respiratory Syncytial Viruses, Drug Design, Crystallography, X-Ray, Amino Acid Motifs, Respiratory Syncytial Virus Vaccines, Mice, Protein Stability, Antibodies, Neutralizing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.